Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS)-Reference-Cited by-同舟云学术

Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS)

Published:2022-08-18 Issue:5 Volume:149 Page:1961-1967
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Hecker-Nolting Stefanie,Baumhoer Daniel,Blattmann Claudia,Kager Leo,Kühne Thomas,Kevric Matthias,Lang Susanna,Mettmann Vanessa,Sorg Benjamin,Werner Matthias,Bielack Stefan S.^ORCID

Funder

Deutsche Krebshilfe

Deutsche Forschungsgemeinschaft

Fördergemeinschaft Kinderkrebs-Zentrum Hamburg

Förderkreis Krebskranke Kinder e.V. Stuttgart

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04156-1.pdf

Reference11 articles.

1. Andreou D, Bielack SS, Carrle D, Kevric M, Kotz R, Winkelmann W, Jundt G, Werner M, Fehlberg S, Kager L, Kühne T, Lang S, Dominkus M, Exner GU, Hardes J, Hillmann A, Ewerbeck V, Heise U, Reichardt P, Tunn PU (2011) The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol 22(5):1228–1235. https://doi.org/10.1093/annonc/mdq589

2. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20(3):776–790. https://doi.org/10.1200/JCO.2002.20.3.776

3. Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, Zoubek A, Werner M, Winkelmann W, Kotz R (2009) Osteosarcoma: the COSS experience. Cancer Treat Res 52:289–308. https://doi.org/10.1007/978-1-4419-0284-9_15

4. Bielack S, Cable MG, Gorlick R, Hecker-Nolting S, Kager L, Marina N; Randall RL, Whelan J. (2021) Osteosarcoma – approach to therapy. In: Arndt CAS (ed.), Sarcomas of bone and soft tissues in children and adolescents pp. 91–109

5. Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone A, Werner M, Monge O, Palmerini E, Berdel WE, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen NL, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci P, Reichardt P (2018) EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: outcome in primary high-grade osteosarcoma. Tumori 104(1):30–36

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells’ Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers;International Journal of Molecular Sciences;2023-05-07

2. Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS);Cancers;2023-02-28

3. TAF1D Functions as a Novel Biomarker in Osteosarcoma;Journal of Cancer;2023

4. Oncology;Bone & Joint 360;2022-12